Delivery Order SPE2DB20D1109-SPE2DB24FP53B
Award Date
7/18/24
Potential Completion Date
7/19/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,173.30, is for the delivery of Vyvanse 40 mg capsules in 100-count bottles. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 7, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,147.14, is for the delivery of 4,567,500 units of the drug Vyvanse 30 mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 10, 2025. The contract was awarded on March 7, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,446.29, is for the delivery of Vyvanse 20 mg capsules in quantities of 100s. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 20, 2025. The contract was awarded on February 19, 2025 and does not have a set-aside designation,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,060.96, is a Delivery Order contract type with a Firm Fixed Price pricing structure. The contract is for the supply of Vyvanse 30 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 16, 2025 and was...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,388.96 firm fixed-price delivery order is for the supply of Vyvanse 60 mg capsules in 100-count bottles. The contract has a completion date of November 8, 2024 and was awarded on November 7, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,646.85, is a delivery order for the supply of Vyvanse 30 mg capsules. The contract has an ultimate completion date of February 10, 2025 and is a firm fixed-price agreement. Amerisourcebergen is the prime contractor on this award, and there is no indication of any set-aside designation. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $4,106.86, is for the delivery of Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price delivery order. This contract award is not associated with a set-aside program. AmerisourceBergen Drug Corp has a significant Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,984.58, is a delivery order for the supply of 4,566,802,553 units of the medication Vyvanse 30 mg capsule. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,224.60, is a Firm Fixed Price Delivery Order for the supply of Vyvanse 30 mg capsules in 100-count packages. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,675.40 and is a delivery order with a firm fixed price. It is for the supply of 4,567,909,459 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...